| Company Name: |
Shanghai YuanYe Biotechnology Co., Ltd.
|
| Tel: |
021-61312847; 18021002903 |
| Email: |
3008007409@qq.com |
| Products Intro: |
Product Name:11-anilino-7,8,9,10-tetrahydrobenzimidazo[1,2-b]isoquinoline-6-carbonitrile CAS:309735-96-4 Purity:98% Package:5mg Remarks:S89767
|
| Company Name: |
DC Chemicals
|
| Tel: |
021-58447131 13564518121 |
| Email: |
doncunbiosci@gmail.com |
| Products Intro: |
Product Name:Usp22i-S02 Purity:98% HPLC Package:100mg,250mg,1g
|
11-anilino-7,8,9,10-tetrahydrobenzimidazo[1,2-b]isoquinoline-6-carbonitrile manufacturers
- USP22-IN-1
-
- $40.00 / 1mg
-
2026-04-20
- CAS:309735-96-4
- Min. Order:
- Purity: 99.37%
- Supply Ability: 10g
|
| | 11-anilino-7,8,9,10-tetrahydrobenzimidazo[1,2-b]isoquinoline-6-carbonitrile Basic information |
| Product Name: | 11-anilino-7,8,9,10-tetrahydrobenzimidazo[1,2-b]isoquinoline-6-carbonitrile | | Synonyms: | 11-anilino-7,8,9,10-tetrahydrobenzimidazo[1,2-b]isoquinoline-6-carbonitrile;Benzimidazo[1,2-b]isoquinoline-6-carbonitrile, 7,8,9,10-tetrahydro-11-(phenylamino)-;Usp22i-S02;USP22-IN-1;11-(Phenylamino)-7,8,9,10-tetrahydrobenzo[4,5]imidazo[1,2-b]isoquinoline-6-carbonitrile | | CAS: | 309735-96-4 | | MF: | C22H18N4 | | MW: | 338.41 | | EINECS: | | | Product Categories: | | | Mol File: | 309735-96-4.mol | ![11-anilino-7,8,9,10-tetrahydrobenzimidazo[1,2-b]isoquinoline-6-carbonitrile Structure](CAS/20180711/GIF/309735-96-4.gif) |
| | 11-anilino-7,8,9,10-tetrahydrobenzimidazo[1,2-b]isoquinoline-6-carbonitrile Chemical Properties |
| density | 1.29±0.1 g/cm3(Predicted) | | storage temp. | -10 to -25°C | | solubility | DMSO: 2mg/mL, clear | | form | powder | | pka | 5.77±0.20(Predicted) | | color | white to beige |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | 11-anilino-7,8,9,10-tetrahydrobenzimidazo[1,2-b]isoquinoline-6-carbonitrile Usage And Synthesis |
| Biological Activity | Cell-permeable and potent inhibitor of ubiquitin specific peptidase 22 (USP22) th at exhibits anticancer activity.
Usp22i-S02 is a cell-permeable benzimidazoisoquinoline-carbonitrile analog th at is shown to reversibly occupy USP22 (ubiquitin specific peptidase 22) catalytic domain and suppress its functions. Usp22i-S02 arrests Usp22-mediated Foxp3 deubiquitination in iTREG cells in a time and dose-dependent manner. Usp22i-S02 administration enhances antitumor immunity with low toxicity in LLC1-challenged mice (20 mg/kg) and reduces tumor burden in a Treg-specific manner. immunity with low toxicity in LLC1-challenged mice (20 mg/kg) and reduces tumor burden in a Treg-specific manner. |
| | 11-anilino-7,8,9,10-tetrahydrobenzimidazo[1,2-b]isoquinoline-6-carbonitrile Preparation Products And Raw materials |
|